“COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW”, YHCĐ, vol. 67, no. 10, Oct. 2026, doi: 10.52163/yhc.v67i10.6921.